| |
Toxicology and applied pharmacology (22 September 2009)
|
| |
The Journal of Comparative Neurology, Vol. 492, No. 2. (2005), pp. 178-192.
|
| |
Parkinsonism & related disorders, Vol. 15, No. 4. (May 2009), pp. 307-314.
|
| |
J. Neurosci., Vol. 29, No. 10. (11 March 2009), pp. 3328-3336.
|
| |
J. Neurosci., Vol. 29, No. 11. (18 March 2009), pp. 3365-3373.
|
| |
J. Neurosci., Vol. 22, No. 3. (1 February 2002), pp. 782-790.
|
| |
Toxicol. Sci., Vol. 61, No. 1. (1 May 2001), pp. 100-106.
|
| |
J Pharmacol Exp Ther, Vol. 305, No. 1. (21 January 2003), pp. jpet.102.043166-218.
|
| |
The Journal of Pain, Vol. 7, No. 9. (September 2006), pp. 611-614.
|
| |
FASEB J. (18 July 2002), 02-0216fje.
|
| |
Journal of Molecular Neuroscience (July 2007), pp. 217-227.
|
| |
Proceedings of the National Academy of Sciences of the United States of America, Vol. 101, No. 32. (10 August 2004), pp. 11851-11856.
|
| |
Fibromyalgia Frontiers, Vol. 13, No. 1. (2005)
|
| |
The journal of pain : official journal of the American Pain Society, Vol. 8, No. 1. (January 2007), pp. 51-58.
|
| |
Free Radical Biology and Medicine, Vol. 45, No. 2. (15 July 2008), pp. 193-200.
|
| |
CRIPS, Vol. 7, No. 4. (2006)
|
| |
Neuropharmacology, Vol. 44, No. 5. (April 2003), pp. 624-632.
|
| |
Journal of Neuroscience Research, Vol. 75, No. 1. (2004), pp. 107-116.
|
| |
Br J Pharmacol (British journal of pharmacology), Vol. 155, No. 2. (9 September 2008)
|